The realisation of Cardiff’s new cancer centre faced substantial financial hurdles, with costs rising significantly.
- Initially tendered at £562m in 2021, the project’s cost has now reached £884.8m following contract finalisation.
- Over 18 months, delays in appointing a project consortium contributed to the £300m cost increase.
- The Acorn consortium, including Sacyr, was confirmed for the project by Velindre University NHS Trust in March.
- Scheduled for completion in 2027, the centre is part of the Welsh government’s innovative public-private partnership model.
The ambitious project to construct a new cancer treatment and research centre in Cardiff witnessed a startling financial escalation over the past year and a half. Initially, the project was priced at £562 million when it went to tender in 2021. However, following the confirmation of a special purpose vehicle contract, the cost has increased to £884.8 million, raising concerns about budget management in major public infrastructure projects.
The delay in confirming the appointment of the project’s consortium, which took 18 months, has been a significant factor in the £300 million cost increase. Velindre University NHS Trust officially announced the contract in March, appointing the Acorn consortium to undertake the design, build, finance, and maintenance of the project. This consortium includes 28 participants, with Spanish multinational contractor Sacyr leading the construction efforts on-site, which commenced in late May.
The new facility is set to replace the existing Velindre Cancer Centre built in 1956, featuring a 32,000 square metre space dedicated to both treatment and research endeavours. Facilities management, upon completion, will be handled by Kier Places, encompassing a comprehensive range of services including maintenance, asset replacement, and performance monitoring, ensuring the centre’s operational efficiency.
Steve Ham, the chief executive of Velindre University NHS Trust, emphasised the project’s significance, stating: “This marks a major milestone in the project to build our much-needed new cancer centre. Now, we will build a world-class NHS facility that will support our staff to deliver care of the highest standard for cancer patients across south Wales and beyond.” His statement underscores the project’s critical role in enhancing healthcare infrastructure in the region.
Notably, the new Velindre cancer hospital is one of three pilot projects under the Welsh government’s Mutual Investment Model, which exemplifies an innovative public-private partnership financing approach. This development model allows private entities to construct and maintain public facilities in exchange for a government fee, ensuring that the asset reverts to public ownership upon contract completion. Other projects included in this scheme involve infrastructure upgrades for roads and educational institutions.
The completion of Cardiff’s cancer centre, despite its financial hurdles, promises significant advancements in regional healthcare infrastructure.
